These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 188467)

  • 1. Guanosine monophosphate synthetase from Ehrlich ascites cells. Multiple inhibition by pyrophosphate and nucleosides.
    Spector T; Jones TE; Krenitsky TA; Harvey RJ
    Biochim Biophys Acta; 1976 Dec; 452(2):597-607. PubMed ID: 188467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanosine monophosphate synthetase from Escherichia coli B-96. Inhibition by nucleosides.
    Spector T; Beacham LM
    J Biol Chem; 1975 Apr; 250(8):3101-7. PubMed ID: 164459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies with GMP synthetase from Ehrlich ascites cells. Purification, properties, and interactions with nucleotide analogs.
    Spector T
    J Biol Chem; 1975 Sep; 250(18):7372-6. PubMed ID: 240826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of 5'-nucleotidase from Ehrlich ascites-tumour cells by nucleoside triphosphates.
    Murray AW; Friedrichs B
    Biochem J; 1969 Jan; 111(1):83-9. PubMed ID: 5775689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INHIBITION OF PRUINE PHOSPHORIBOSYLTRANSFERASES OF EHRLICH ASCITES-TUMOUR CELLS BY 6-MERCAPTOPURINE.
    ATKINSON MR; MURRAY AW
    Biochem J; 1965 Jan; 94(1):64-70. PubMed ID: 14342250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Phosphoribosyl pyrophosphate synthetase from Ehrlich ascites tumor cells.
    Wong PC; Murray AW
    Biochemistry; 1969 Apr; 8(4):1608-14. PubMed ID: 4309335
    [No Abstract]   [Full Text] [Related]  

  • 7. Dinucleosidetetraphosphatase from Ehrlich ascites tumour cells: inhibition by adenosine, guanosine and uridine 5'-tetraphosphates.
    Moreno A; Lobatón CD; Sillero MA; Sillero A
    Int J Biochem; 1982; 14(7):629-34. PubMed ID: 6286385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian adenylosuccinate lyase. Participation in the conversion of 2'-dIMP and beta-D-arabinosyl-IMP to adenine nucleotides.
    Spector T
    Biochim Biophys Acta; 1977 Apr; 481(2):741-5. PubMed ID: 300632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic and regulatory properties of pyruvate dehydrogenase from Ehrlich ascites tumor cells.
    Siess EA; Nimmannit S; Wieland OH
    Cancer Res; 1976 Jan; 36(1):55-9. PubMed ID: 174813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the nature of the regulation by purine nucleotides of adenine phosphoribosyltransferase and of hypoxanthine phosphoribosyltransferase from Ehrlich ascites-tumour cells.
    Murray AW
    Biochem J; 1967 Apr; 103(1):271-9. PubMed ID: 6068004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of purine metabolism in Ehrlich ascites tumor cells in vitro.
    Lau KF; Henderson JF
    Cancer Chemother Rep 2; 1972 Nov; 3(1):95-109. PubMed ID: 4499907
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of amino acids, adenine nucleotides and inorganic pyrophosphate on glutamine synthetase from Anabaena cylindrica.
    Sawhney SK; Nicholas DJ
    Biochim Biophys Acta; 1978 Dec; 527(2):485-96. PubMed ID: 31917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and properties of CTP synthetase from Ehrlich ascites tumor cells.
    Kizaki H; Sakurada T; Weber G
    Biochim Biophys Acta; 1981 Nov; 662(1):48-54. PubMed ID: 7306558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of adenosine and deoxyadenosine in Ehrlich ascites carcinoma cells resistant to 6-(Methylmercapto)purine ribonucleoside.
    Lomax CA; Henderson JF
    Can J Biochem; 1972 Apr; 50(4):423-7. PubMed ID: 4537315
    [No Abstract]   [Full Text] [Related]  

  • 15. Homogeneous uridine kinase from Ehrlich ascites tumor: substrate specificity and inhibition by bisubstrate analogs.
    Cheng N; Payne RC; Kemp WE; Traut TW
    Mol Pharmacol; 1986 Aug; 30(2):159-63. PubMed ID: 3016499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent.
    Streeter DG; Witkowski JT; Khare GP; Sidwell RW; Bauer RJ; Robins RK; Simon LN
    Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1174-8. PubMed ID: 4197928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of (2'-5')(A)n from ATP. Characteristics of the reaction catalyzed by (2'-5')(A)n synthetase purified from mouse Ehrlich ascites tumor cells treated with interferon.
    Samanta H; Dougherty JP; Lengyel P
    J Biol Chem; 1980 Oct; 255(20):9807-13. PubMed ID: 6159349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some properties of adenosine kinase from Ehrlich ascites-tumour cells.
    Murray AW
    Biochem J; 1968 Jan; 106(2):549-55. PubMed ID: 5688928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FLUORINATED PYRIMIDINES. XXV. THE INHIBITION OF THYMIDYLATE SYNTHETASE FROM EHRLICH ASCITES CARCINOMA CELLS BY PYRIMIDINE ANALOGS.
    REYES P; HEIDELBERGER C
    Biochim Biophys Acta; 1965 May; 103():177-9. PubMed ID: 14336436
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitors of hypoxanthine metabolism in Ehrlich ascites tumor cells in vitro.
    Smith CM; Zombor G; Henderson JF
    Cancer Treat Rep; 1976 Oct; 60(10):1567-84. PubMed ID: 191189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.